First American Bank’s Edwards Lifesciences EW Stock Holding History

First American Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Sell	143,763 -5,639	-4%	-$472K	0.73%	36
2026 Q1	$12M	Buy	149,402 +227	+0.2%	+$18.7K	0.75%	35
2025 Q4	$12.7M	Buy	149,175 +5,971	+4%	+$490K	0.77%	31
2025 Q3	$11.1M	Buy	143,204 +561	+0.4%	+$43.8K	0.7%	39
2025 Q2	$11.2M	Sell	142,643 -536	-0.4%	-$40K	0.76%	35
2025 Q1	$10.4M	Buy	143,179 +1,908	+1%	+$137K	0.77%	36
2024 Q4	$10.5M	Sell	141,271 -1,036	-0.7%	-$72.5K	0.74%	36
2024 Q3	$9.39M	Sell	142,307 -1,624	-1%	-$118K	0.67%	38
2024 Q2	$13.3M	Sell	143,931 -1,697	-1%	-$150K	1%	26
2024 Q1	$13.9M	Buy	145,628 +2,800	+2%	+$235K	1.05%	25
2023 Q4	$10.9M	Buy	142,828 +4,752	+3%	+$331K	0.91%	32
2023 Q3	$9.57M	Sell	138,076 -3,891	-3%	-$313K	0.87%	31
2023 Q2	$13.4M	Sell	141,967 -32,570	-19%	-$2.83M	1.16%	21
2023 Q1	$14.4M	Buy	174,537 +24,744	+17%	+$1.94M	1.32%	20
2022 Q4	$11.2M	Sell	149,793 -1,239	-0.8%	-$95.5K	1.07%	24
2022 Q3	$12.5M	Sell	151,032 -240	-0.2%	-$23.1K	1.3%	20
2022 Q2	$14.4M	Sell	151,272 -71	-0%	-$7.35K	1.46%	16
2022 Q1	$17.8M	Sell	151,343 -6	-0%	-$673	1.51%	15
2021 Q4	$19.6M	Buy	151,349 +100	+0.1%	+$11.7K	1.04%	27
2021 Q3	$17.1M	Sell	151,249 -516	-0.3%	-$58.9K	0.99%	29
2021 Q2	$15.7M	Sell	151,765 -778	-0.5%	-$73.3K	0.91%	31
2021 Q1	$12.8M	Buy	152,543 +580	+0.4%	+$49K	0.8%	34
2020 Q4	$13.9M	Sell	151,963 -8,878	-6%	-$736K	0.93%	27
2020 Q3	$12.8M	Sell	160,841 -115	-0.1%	-$8.97K	0.76%	33
2020 Q2	$11.1M	Sell	160,956 -1,332	-0.8%	-$94.7K	0.7%	35
2020 Q1	$10.2M	Sell	162,288 -903	-0.6%	-$65.1K	0.76%	29
2019 Q4	$12.7M	Buy	+163,191	New	+$12.7M	0.79%	30
2019 Q2	$10.2M	Sell	164,973 -3,021	-2%	-$183K	0.7%	38
2019 Q1	$10.7M	Sell	167,994 -3,363	-2%	-$192K	0.77%	33
2018 Q4	$8.75M	Sell	171,357 -927	-0.5%	-$46.9K	0.68%	41
2018 Q3	$10M	Buy	+172,284	New	+$8.43M	0.69%	42
2018 Q1	$8.3M	Sell	178,443 -7,143	-4%	-$310K	0.63%	49
2017 Q4	$6.97M	Sell	185,586 -1,386	-0.7%	-$50.9K	0.53%	56
2017 Q3	$6.81M	Sell	186,972 -15,174	-8%	-$579K	0.52%	55
2017 Q2	$7.97M	Sell	202,146 -1,794	-0.9%	-$65.5K	0.63%	43
2017 Q1	$6.39M	Sell	203,940 -108,327	-35%	-$3.39M	0.52%	54
2016 Q4	$9.75M	Sell	312,267 -18,849	-6%	-$611K	0.82%	28
2016 Q3	$13.3M	Sell	331,116 -71,352	-18%	-$2.69M	1.22%	15
2016 Q2	$13.4M	Sell	402,468 -75,666	-16%	-$2.59M	1.29%	16
2016 Q1	$14.1M	Sell	478,134 -21,828	-4%	-$602K	1.39%	14
2015 Q4	$13.2M	Sell	499,962 -1,950	-0.4%	-$50.6K	1.34%	19
2015 Q3	$11.9M	Buy	501,912 +80,658	+19%	+$1.95M	1.3%	21
2015 Q2	$10M	Buy	+421,254	New	+$9.51M	0.99%	32

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

First American Bank's EW Position: Q2 2026 in Review

First American Bank reduced its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, selling an estimated $472K and leaving 143,763 shares worth $13M. The position accounts for 0.73% of the portfolio, ranked #36.

First American Bank first reported a position in EW in Q2 2015 and has held it in 43 quarters since. The position peaked at $19.6M in Q4 2021. 529 funds tracked by Wall St. Rank hold EW as of Q2 2026.

First American Bank held 143,763 shares of Edwards Lifesciences worth $13M as of Q2 2026.
First American Bank sold 5,639 Edwards Lifesciences shares in Q2 2026, an estimated $472K.
Edwards Lifesciences made up 0.73% of First American Bank's portfolio in Q2 2026, its #36 holding.
First American Bank first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 43 quarters since.
First American Bank's Edwards Lifesciences position peaked at $19.6M in Q4 2021.
529 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.